tm
Seeing Is Believing
tm
Seeing Is Believing
PRME is currently covered by 4 analysts with an average price target of $8.07. This is a potential upside of $5.02 (149.07%) from yesterday's end of day stock price of $3.24.
Prime Medicine, Common Stock's activity chart (see below) currently has 40 price targets and 43 ratings on display. The stock rating distribution of PRME is 60% BUY and 40% HOLD.
Analysts average stock forecasts to be materialized ratio is 17.46% with an average time for these price targets to be met of 50.76 days.
Highest price target for PRME is $11, Lowest price target is $4.25, average price target is $8.07.
Most recent stock forecast was given by ARTHUR HE from HC WAINWRIGHT on 10-Aug-2026. First documented stock forecast 13-Nov-2022.
Currently out of the existing stock ratings of PRME, 3 are a BUY (60%), 2 are a HOLD (40%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2026
$8
$4.91 (158.90%)
$8
Buy Since 09-Oct-2023
$11
$7.57 (220.70%)
$10
Hold Since 11-Nov-2025
$4.25
$0.82 (23.91%)
Buy Since 22-Apr-2024
$9
$5.57 (162.39%)
$10
Buy Since 31-Jul-2023
$5
$1.57 (45.77%)
What is PRME (Prime Medicine, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on PRME (Prime Medicine, Common Stock) with a proven track record?
Which analyst has the most public recommendations on PRME (Prime Medicine, Common Stock)?
Which analyst is the currently most bullish on PRME (Prime Medicine, Common Stock)?
Which analyst is the currently most reserved on PRME (Prime Medicine, Common Stock)?
